将多部门分子特性整合到针对新诊断的质母细胞瘤患者的个性化类疫苗设计中
Tanner M Johanns1,2,3, Elizabeth A R Garfinkle4, Katherine E Miller4
1Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri.
概括
个性化癌症疫苗NeoVax成功刺激了质母细胞瘤患者的免疫反应. 这种使用多部门测序的方法扩大了新抗原点,以改善免疫疗法开发.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 基因组学就是基因组学.
背景情况:
- 尽管采用标准治疗方法,质母细胞瘤 (GBM) 的结局仍然很差.
- 由于瘤免疫性较低,免疫疗法选择有限.
- 目前的癌症疫苗研究使用有限的单个瘤部位数据,忽视了GBM异质性.
研究的目的:
- 为了评估NeoVax的疗效,一个个性化的疫苗,在质母细胞瘤患者.
- 评估多部门测序对扩大癌症疫苗新抗原标的影响.
- 报告NeoVax临床试验 (NCT0342209) 中四名患者的发现.
主要方法:
- 多部门测序以识别整个GBM基因组景观中的更广泛的新抗原池.
- 个性化类疫苗 (NeoVax) 的开发.
- 使用IFNγ-ELISPOT测定对周围血液单核细胞疫苗接种前和后的免疫反应性的评估.
- 对T细胞透和扩张的瘤活检的分析.
主要成果:
- 疫苗接种后观察到IFNγ产生T细胞的统计学上显著增加,这些T细胞特异于NeoVax新抗原.
- 瘤活检分析显示,一个患者的T细胞透,克隆扩张.
- 在癌症疫苗设计中证明了多部门采样的可行性.
结论:
- 在质母细胞瘤患者中,NeoVax有效地刺激新抗原特异性T细胞.
- 这些发现支持未来基于新抗原疫苗的临床试验对GBM的开发.
- 突出了多部门采样的临床适用性,以了解新抗原景观.
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...